BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31390635)

  • 1. Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.
    Ogimi T; Sadahiro S; Kamei Y; Chan LF; Miyakita H; Saito G; Okada K; Suzuki T; Kajiwara H
    Oncology; 2019; 97(5):294-300. PubMed ID: 31390635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
    Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
    BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and Prognostic Evaluations of Mixed Adenoneuroendocrine Carcinoma of the Colon and Rectum: A Case-Matched Study.
    Watanabe J; Suwa Y; Ota M; Ishibe A; Masui H; Nagahori K; Tsuura Y; Endo I
    Dis Colon Rectum; 2016 Dec; 59(12):1160-1167. PubMed ID: 27824701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic characteristics of colorectal neuroendocrine tumor].
    Jung SH; Kim HC; Yu CS; Chang HM; Ryu MH; Lee JL; Kim JS; Kim JC
    Korean J Gastroenterol; 2006 Aug; 48(2):97-103. PubMed ID: 16929153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
    Gulubova M; Vlaykova T
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
    Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
    Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
    Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
    J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is neuroendocrine differentiation useful to discriminate primary sinonasal intestinal-type adenocarcinomas from metastatic colorectal adenocarcinomas?
    Projetti F; Serrano E; Vergez S; Bissainthe AC; Delisle MB; Uro-Coste E
    J Clin Pathol; 2015 Jan; 68(1):79-82. PubMed ID: 25294889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 12. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of primary combined neuroendocrine carcinoma with squamous cell carcinoma in the upper gingiva.
    Mochizuki Y; Omura K; Sakamoto K; Nakanishi S; Satoh K; Marukawa E; Yamaguchi A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):e34-9. PubMed ID: 20303044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma.
    Wick MR; Vitsky JL; Ritter JH; Swanson PE; Mills SE
    Am J Clin Pathol; 2005 Jan; 123(1):56-65. PubMed ID: 15762280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptophysin and chromogranin A expression analysis in human tumors.
    Uhlig R; Dum D; Gorbokon N; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Sauter G; Wilczak W; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Simon R; Minner S
    Mol Cell Endocrinol; 2022 Sep; 555():111726. PubMed ID: 35921917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.
    Wu Y; Lai Y; Zhang M; Li Z
    Diagn Pathol; 2021 Aug; 16(1):78. PubMed ID: 34454530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of synchronous double primary lung cancer with neuroendocrine features.
    Niho S; Yokose T; Nagai K; Nishiwaki Y; Kodama T; Mukai K
    Jpn J Clin Oncol; 1999 Apr; 29(4):219-25. PubMed ID: 10340047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
    Miremadi A; Pinder SE; Lee AH; Bell JA; Paish EC; Wencyk P; Elston CW; Nicholson RI; Blamey RW; Robertson JF; Ellis IO
    Histopathology; 2002 Mar; 40(3):215-22. PubMed ID: 11895486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.
    Atasoy P; Ensari A; Demirci S; Kurşun N
    Tumori; 2003; 89(1):49-53. PubMed ID: 12729362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.